Posted in | News

Excelitas Technologies Announces Agreement to Acquire Axsun Technologies

Excelitas Technologies, a global technology leader focused on delivering innovative, customized photonic solutions, today announced that it has signed a definitive agreement to acquire Axsun Technologies (Billerica, MA USA).  Axsun is a privately-held company specializing in the development and production of innovative, MEMS-based light engines for high performance medical imaging and industrial spectroscopy applications.

Terms of the agreement are not being disclosed and the transaction is expected to close in early 2019.

For more information on Excelitas, visit www.excelitas.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Excelitas Technology. (2019, March 19). Excelitas Technologies Announces Agreement to Acquire Axsun Technologies. AZoOptics. Retrieved on November 23, 2024 from https://www.azooptics.com/News.aspx?newsID=24050.

  • MLA

    Excelitas Technology. "Excelitas Technologies Announces Agreement to Acquire Axsun Technologies". AZoOptics. 23 November 2024. <https://www.azooptics.com/News.aspx?newsID=24050>.

  • Chicago

    Excelitas Technology. "Excelitas Technologies Announces Agreement to Acquire Axsun Technologies". AZoOptics. https://www.azooptics.com/News.aspx?newsID=24050. (accessed November 23, 2024).

  • Harvard

    Excelitas Technology. 2019. Excelitas Technologies Announces Agreement to Acquire Axsun Technologies. AZoOptics, viewed 23 November 2024, https://www.azooptics.com/News.aspx?newsID=24050.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Featured Equipment

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback